Mobic and Flaxseed drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mobic (meloxicam) and Flaxseed (flaxseed). Common drug interactions include muscular weakness among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Mobic and Flaxseed. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.

What is Flaxseed?

Flaxseed has active ingredients of flaxseed. It is often used in high blood cholesterol. eHealthMe is studying from 7,137 Flaxseed users. Check the latest studies of Flaxseed.



On Aug, 11, 2026

59 people who take Mobic and Flaxseed together, and have interactions are studied.

Mobic and Flaxseed drug interactions.

What are the common drug interactions of Mobic and Flaxseed, by gender? *:

female:

  1. Muscular weakness (muscle weakness)
  2. Pancreatitis (inflammation of pancreas)
  3. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  4. Platelet count increased
  5. Procedural complication
  6. Procedural pain
  7. Pulmonary granuloma (tiny lump of inflamed tissue in the lungs)
  8. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  9. Seroma (a tumour like collection of serum in the tissues)
  10. Serositis (inflammation of the serous tissues of the body)

male:

  1. Dehydration (dryness resulting from the removal of water)
  2. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  3. Hyperglycaemia (high blood sugar)
  4. Oedema (fluid collection in tissue)
  5. Overweight
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Gastroduodenal haemorrhage (bleeding from stomach or duodenum ulcer)
  8. Hypertension (high blood pressure)
  9. Iron deficiency anaemia
  10. Memory impairment

What are the common drug interactions of Mobic and Flaxseed, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthenia (weakness)
  2. Chills (felling of cold)
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Pyrexia (fever)
  6. Abdominal distension
  7. Abdominal hernia
  8. Abdominal mass (localized enlargement or swelling in the human abdomen)
  9. Abdominal pain lower
  10. Abdominal wall abscess (abdominal wall infection)

50-59:

  1. Bladder pain
  2. Blood glucose decreased
  3. Blood glucose increased
  4. Chest discomfort
  5. Chills (felling of cold)
  6. Colitis ulcerative (inflammation of colon with ulcer)
  7. Diabetes mellitus inadequate control
  8. Diverticular perforation (serious gastrointestinal condition in which the intestine's walls are perforated)
  9. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  10. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)

60+:

  1. Lung infection
  2. Plasma cell myeloma (cancer that begins in plasma cells)
  3. Chest pain
  4. Colitis (inflammation of colon)
  5. Diarrhoea
  6. Drug ineffective
  7. Fatigue (feeling of tiredness)
  8. Gastroduodenal haemorrhage (bleeding from stomach or duodenum ulcer)
  9. Headache (pain in head)
  10. Hypersensitivity

What are the existing conditions these people have? *

  1. High Blood Pressure: 15 people, 25.42%
  2. Pain: 11 people, 18.64%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 18.64%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 16.95%
  5. Muscle Spasms (muscle contraction): 9 people, 15.25%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 13.56%
  7. Nausea (feeling of having an urge to vomit): 4 people, 6.78%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 6.78%
  9. Chest Pain: 4 people, 6.78%
  10. Back Pain: 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Mobic and Flaxseed?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mobic and Flaxseed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flaxseed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flaxseed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and flaxseed (the active ingredients of Mobic and Flaxseed, respectively), and Mobic and Flaxseed (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: